Mak, Anthony. “IL-17 Inhibitors and the Risk of Malignancy”. Canadian Dermatology Today 3, no. 1 (March 1, 2022): 21–24. Accessed November 21, 2024. https://canadiandermatologytoday.com/article/view/3-1-mak.